IN SILICO STUDY OF ANTI-TYPE II DIABETES ACTIVITY OF XANTHONES WITH MOLECULAR DOCKING AND MOLECULAR DYNAMICS APPROACH
Type 2 diabetes mellitus (DM) is a disease caused by insulin resistance. This disease causes hyperglycemic conditions (high blood sugar levels) that may lead to organ failure. Many types of type 2 DM medication exist, such as oral medication. Oral medication can be divided into six classes: bigua...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/61418 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Type 2 diabetes mellitus (DM) is a disease caused by insulin resistance. This
disease causes hyperglycemic conditions (high blood sugar levels) that may lead to
organ failure. Many types of type 2 DM medication exist, such as oral medication.
Oral medication can be divided into six classes: biguanide, sulphonylurea, glinide,
thiazolidinedione, dipeptidyl peptidase IV inhibitor and alpha glucosidase
inhibitor. Although many types of oral medications have been discovered, the
effectiveness and efficacy varies between patients, which means that there is still a
need for an alternative to the existing treatments in the market. One compound
group that has gained a lot of scientific interest in its antidiabetic potential is
xanthones as inhibitors of two complex carbohydrate metabolizing enzymes, alphaglucosydase
and alpha-amylase. The inhibition of these enzymes decrease the
degradation of carbohydrates into glucose, resulting in the inhibition of the
increase of blood glucose concentration. In this research, 515 three-dimensional
and SMILES structures of xanthones are either collected from Pubchem (if
available) or created using Avogadro. Ligands are typed with CHARMM forcefield
and MMFF94 partial charge prior to docking to alpha-glucosidase (PDB Code:
2QMJ) and alpha-amylase (PDB Code: 1XD0) using PyRx. The SMILES structures
are used to estimate the toxicity (oral rat LD50) and predict the physicochemical
features of each xanthone. Xanthones with binding affinities higher of equal to the
top tenth percentile of xanthones and oral rat LD50 values of over 500 mg/kg will
have their interactions with their respective protein targets examined. In total, there
are thirty-one (31) unique ligands that fulfill the cut-off values. Out of the 31
xanthones, ten are glycosylated xanthones, two are xanthonologinoids, and nine
are prenylated xanthones. All 31 ligands and the standard ligand are predicted to
inhibit the protein’s active site. As a result, all ligands have at least one interaction
with the active site residues and residues that interact with the standard ligand. The
residues found to interact with all the ligands aer Asp542 and Phe575 for protein
target 2QMJ and His201 and Glu233 for protein target 1XD0. Three xanthones are
chosen as the best inhibitors based on the amount of interactions with the active
site residues and residues that interact with the standard ligand. The three best
inhibitors for 2QMJ are L140 (3,4,5,8-Tetrahydroxy-1,2-diisoprenylxanthone),
L449 (Polygalaxanthone V), and L451 (Polygalaxanthone VII), while the three
best inhibitors for 1XD0 are L115 (1-O-primeverosyl-3,8-dihydroxy-5- methoxyxanthone), L316 (Garcimangosone C), and L393 (Mangostinone). All three
ligands of 2QMJ were found to interact with 100% of the protein’s active site
residues, while all three ligands of 1XD0 had the most interactions with the active
sites and standard ligand interaction sites, as well as interact with the three
catalytic sites of protein 1XD0. All six ligands and the standard ligands were able
to advance to the molecular dynamics simulation. The simulation is performed
using GROMACS for 2 ns, with the CHARMM force field and TIP3P water model.
Before performing the production stage, system equilibration was performed at a
constant temperature and pressure of 310 K and 1 atm using the NVT and NPT
ensemb and energy minimization was performed using the steepest descent
algorithm. From the graphs of potential energy, temperature, and density of the
system, it was found that equilibration and minimization were successfully
performed on all eight systems. From the results of the production stage, all systems
were found to fluctuate in terms of interaction energy, number of interactions, and
the types of interactions formed. The standard ligand always had the strongest
interaction energy, while prenylated xanthones always had the weakest interaction
energy. However, prenylated xanthones showed better ability in keeping most of
their initial interactions constant from the beginning, middle, to the end of the
simulation compared to the standard ligand and glycosylated xanthones. |
---|